These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29338150)

  • 1. The role of cannabinoids in pain control: the good, the bad, and the ugly.
    Pergolizzi JV; Lequang JA; Taylor R; Raffa RB; Colucci D;
    Minerva Anestesiol; 2018 Aug; 84(8):955-969. PubMed ID: 29338150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
    Boychuk DG; Goddard G; Mauro G; Orellana MF
    J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoids in the Treatment of Back Pain.
    Kim TE; Townsend RK; Branch CL; Romero-Sandoval EA; Hsu W
    Neurosurgery; 2020 Aug; 87(2):166-175. PubMed ID: 32097466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.
    Kamrul R; Bunka D; Crawley A; Schuster B; LeBras M
    Can Fam Physician; 2019 Nov; 65(11):807-811. PubMed ID: 31722915
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropathic orofacial pain: cannabinoids as a therapeutic avenue.
    McDonough P; McKenna JP; McCreary C; Downer EJ
    Int J Biochem Cell Biol; 2014 Oct; 55():72-8. PubMed ID: 25150831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
    Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
    Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the analgesic efficacy of cannabinoid medications in the management of acute pain.
    Stevens AJ; Higgins MD
    Acta Anaesthesiol Scand; 2017 Mar; 61(3):268-280. PubMed ID: 28090652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cannabinoids in the management of neuropathic pain.
    Martín Fontelles MI; Goicoechea García C
    CNS Drugs; 2008; 22(8):645-53. PubMed ID: 18601303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks.
    Ang SP; Sidharthan S; Lai W; Hussain N; Patel KV; Gulati A; Henry O; Kaye AD; Orhurhu V
    Pain Ther; 2023 Apr; 12(2):355-375. PubMed ID: 36639601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabinoids for the treatment of chronic pain - an overview of current medical knowledge].
    Gras-Ozimek J; Kozińska U; Gras-Ozimek A
    Pol Merkur Lekarski; 2022 Aug; 50(298):257-261. PubMed ID: 36086988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoids for neuropathic pain.
    Fine PG; Rosenfeld MJ
    Curr Pain Headache Rep; 2014 Oct; 18(10):451. PubMed ID: 25160710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
    Ashton JC; Milligan ED
    Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cannabinoids for neuropathic pain management].
    Andersen LØ; Enggaard TP; Højsted J
    Ugeskr Laeger; 2018 Feb; 180(9):. PubMed ID: 29506645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
    Häuser W; Petzke F; Fitzcharles MA
    Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabinoids in pain medicine].
    Karst M
    Schmerz; 2018 Oct; 32(5):381-396. PubMed ID: 29881935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.